Lysine methylation of promoter-bound transcription factors and relevance to cancer
- PMID: 21151202
- PMCID: PMC3193425
- DOI: 10.1038/cr.2010.174
Lysine methylation of promoter-bound transcription factors and relevance to cancer
Abstract
p53, NFκB, STAT3, and several other transcription factors are reversibly methylated on lysine residues by enzymes that also modify histones. The methylations of NFκB and STAT3 take place when they are bound to promoters, suggesting a more general model in which the binding of inducible transcription factors to DNA helps to recruit chromatin-modification machinery, which then may modify not only histones but also the bound transcription factors. Mutations of some histone-lysine methyltransferases and demethylases are linked to cancer, and these mutations may alter the methylation not only of histones but also of transcription factors, and thus may be tumorigenic through more than one mechanism.
Figures
References
-
- Wolffe AP. Transcriptional regulation in the context of chromatin structure. Essays Biochem. 2001;37:45–57. - PubMed
-
- Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403:41–45. - PubMed
-
- Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693–705. - PubMed
-
- Sims RJ, III, Reinberg D. Histone H3 Lys 4 methylation: caught in a bind. Genes Dev. 2006;20:2779–2786. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
